1-3 of 3
Teresa M. O’Brien
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine Plus Mitoxantrone Followed by Yttrium-90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) and Maintenance Rituximab as Front Line Therapy for Patients with Intermediate or High Risk Follicular Non-Hodgkin’s Lymphoma.

Stephanie A. Gregory, MD, Mohamad Kassar, M.D., Henry C. Fung, M.D., Parameswaran Venugopal, M.D., Teresa M. O’Brien, Michelle Tenuto
Journal: Blood
Blood (2007) 110 (11): 1360.
https://doi.org/10.1182/blood.V110.11.1360.1360
Published: 2007
Journal Articles

Safety and Efficacy of Fludarabine Plus Mitoxantrone (FM) Followed by Yttrium-90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin ® ) and Maintenance Rituximab in Intermediate- to High-Risk Newly Diagnosed and Relapsed Follicular Non-Hodgkin’s Lymphoma (NHL).

Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Jamile M. Shammo, MD, Teresa M. O’Brien, RN, Amjad Ali, MD
Journal: Blood
Blood (2005) 106 (11): 4789.
https://doi.org/10.1182/blood.V106.11.4789.4789
Published: 2005
Journal Articles

Radioimmunotherapy with I 131 Tositumomab in Relapsed and Transformed Low-Grade (LG) Non-Hodgkin’s Lymphoma (NHL): Long-Term Follow-Up of a Single Institution Experience.

Huma Qawi, Teresa M. O’Brien, Parameswaran Venugopal, Jamile Shammo, Elena Bogdanova, Stephanie A. Gregory
Journal: Blood
Blood (2004) 104 (11): 4641.
https://doi.org/10.1182/blood.V104.11.4641.4641
Published: 2004